Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

New York Eye and Ear Infirmary, New York

Flaum Eye Institute, University of Rochester Medical Center, Rochester

Allegheny Ophthalmic and Orbital Associates, Pittsburgh

University of Pennsylvania, Department of Ophthalmology, Philadelphia

Virginia Commonwealth University, Richmond

Duke Eye Center, Duke University Medical Center, Durham

Charlotte Eye, Ear, Nose and Throat Associates, PA, Charlotte

Western Carolina Retinal Associates, Asheville

Bascom Palmer at the University of Miami, Miami

Bnai Zion Medical Center, Haifa

Sarasota Retina Institute, Sarasota

University of Kentucky, Department of Ophthalmology, Lexington

Cole Eye Institute, Cleveland Clinic Foundation, Cleveland

Rabin Medical Center, Belinson Campus, Dept of Ophthalmology, Petah Tikva

The Chaim Sheba Medical Center, Dept of Ophthalmology, Tel Litwinsky

University of Minnesota, Department of Ophthalmology, Minneapolis

University of Illinois at Chicago, Eye and Ear Infirmary, Chicago

The Tel-Aviv Sourasky Medical Center, Dept of Ophthalmology, Tel Aviv

Mason Eye Institute, University of Missouri, Columbia

Kansas University Medical Center, Kansas City

Kaplan Medical Center, Department of Ophthalmology, Rehovot

Alkek Eye Center Baylor College of Medicine, Houston

Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus, University of Colorado, Aurora

Soroka University Medical Center, Dept of Ophthalmology, Beersheba

John A. Moran Eye Center at the University of Utah, Salt Lake City

Retinal Consultants of Arizona, Phoenix

Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles

Retina-Vitreous Associates Medical Group, Beverly Hills